Oxford Biomedica plc (LON:OXB)

Market Cap	796.56M +100.4%
Revenue (ttm)	151.21M +55.4%
Net Income	-37.07M
EPS	-0.36
Shares Out	120.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,761
Average Volume	419,614
Open	656.00
Previous Close	659.00
Day's Range	646.00 - 659.00
52-Week Range	232.50 - 962.00
Beta	1.04
RSI	30.26
Earnings Date	Mar 26, 2026

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and de...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 900
• Stock Exchange: London Stock Exchange
• Ticker Symbol: OXB

Financial Performance

In 2024, Oxford Biomedica's revenue was 128.80 million, an increase of 43.84% compared to the previous year's 89.54 million. Losses were -43.19 million, -72.58% less than in 2023.